• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmedicine

CVS, Walmart and Walgreens-brand Mucinex may contain potent carcinogen benzene

By
Anna Edney
Anna Edney
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Anna Edney
Anna Edney
and
Bloomberg
Bloomberg
Down Arrow Button Icon
August 12, 2024, 7:25 AM ET
Miami Beach, Fla., Walgreens, Pharmacy over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex.
Miami Beach, Fla., Walgreens, Pharmacy over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex. Jeffrey Greenberg—Universal Images Group/Getty Images

While it may seem like the only difference between extended-release Mucinex and its generic store-brand counterpart is the price tag, the latter potentially exposes users to a deadly cancer-causing chemical. 

Millions of Americans who buy the store-brand option at various major US chains are unknowingly choosing a drug that risks containing a potent carcinogen called benzene, according to a Bloomberg analysis of government data. Benzene can cause blood cancers such as leukemia and lymphoma. 

Just looking at the boxes, consumers wouldn’t easily be able to spot the difference between the two medicines. They both contain the same active ingredient, guaifenesin. And while the inactive ingredients differ, benzene isn’t listed among them. It instead lurks in an inactive ingredient, a white powder called a carbomer.

Both medicines use carbomers to create an extended-release phenomenon that helps relieve symptoms over a 12-hour period. But while the brand-name version, sold by the British drugmaker Reckitt Benckiser Group Plc, uses a carbomer that isn’t made with benzene, the generic ones sold as store brands by CVS, Walmart, Target and Walgreens use a cheaper one made with the harmful chemical, Bloomberg found.

US regulators have allowed drugmakers to use benzene for decades, even though international authorities have said they shouldn’t. In recent years, testing has found dangerously high levels of the chemical in some products in the US, raising concerns. Last year, the US Food and Drug Administration said the ingredient would be phased out of pharmaceutical use in 2025, a deadline that has been extended to 2026 following industry complaints.

“The FDA is continuously working to ensure that all drugs meet the highest quality standards with the health and well-being of Americans top of mind,” Amanda Hils, a spokesperson for the agency, said.

In response to Bloomberg’s questions about generic Mucinex having benzene, CVS Health Corp. said the company would work with its supplier to replace the ingredient. Walgreens Boots Alliance Inc. said it works with its suppliers to follow FDA regulations. Walmart Inc., Target Corp. and Rite Aid Corp. didn’t respond to requests for comment.

The FDA has also been studying drugs sold in gel form that use carbomers. Tablets, like generic Mucinex, are not included in that analysis, Hils said. She didn’t offer details on the results of the testing. 

Bloomberg’s analysis found a few dozen drugs besides generic Mucinex that still contain carbomers made using benzene including Walgreens’ version of Anbesol, an oral pain reliever; Walmart’s Equate brand face moisturizer with sunscreen; and Rite Aid’s version of Bengay muscle rub. 

While most shoppers trust that store-brand medicines are just as safe and effective as brand-name ones, that’s not always true. Generic drugs of all sorts, from eye drops to cancer treatments, have been linked to factories using unsafe practices, often to cut costs.

When it comes to store-brand generics, the retailer isn’t responsible for the quality of the products it sells. Instead, oversight and liability lies with the manufacturer. 

In the case of generic Mucinex, the major US chains all source their extended-release mucus-relief medicine from the same New Jersey company, Amneal Pharmaceuticals Inc. The drugmaker didn’t respond to requests for comment, including questions about whether it tested its drugs for potential benzene contamination or how it plans to comply with upcoming FDA regulations. 

Swapping ingredients is “dramatically costly and dramatically time consuming” because it requires additional testing and another round of FDA approval, said Vivek Dave, an associate professor of pharmaceutical sciences at St. John Fisher University in New York. 

Prices for carbomers are not made public and companies that sell them contacted by Bloomberg didn’t respond to inquiries. On Amazon, India-based Bangalore Fine Chemicals lists about four ounces of a carbomer made with benzene for $4 less than the one without. Drugmakers buying in bulk would potentially have to pay hundreds of thousands of dollars more for a less risky carbomer.

The inventor of Mucinex says there’s no scientific or therapeutic reason to use a carbomer made with benzene. “Clearly, benzene is not viewed fondly,” said Jeff Keyser, who’s now the chief executive officer of a pharmaceutical startup called Renibus Therapeutics in Texas. “There are other things out there they can use.” 

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Authors
By Anna Edney
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Health

Healthmeal delivery
The Best Meal Delivery Services for Weight Loss of 2025: Dietitian Approved
By Christina SnyderDecember 11, 2025
19 hours ago
Best protein lead image
HealthDietary Supplements
The 8 Best Protein Powders of 2025: How to Choose, According to an RD
By Christina SnyderDecember 9, 2025
3 days ago
Transparent Labs Creatine HMB as best creatine
HealthDietary Supplements
The Best Creatine Supplements of 2025: Tested and Approved
By Christina SnyderDecember 9, 2025
3 days ago
Jon Rosemberg
CommentaryProductivity
The cult of productivity is killing us
By Jon RosembergDecember 9, 2025
3 days ago
Trump
CommentaryTariffs and trade
AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
By Bob Kocher, Bryan Roberts and Siobhan Nolan ManginiDecember 9, 2025
3 days ago
Kevin Kiley
PoliticsElections
‘It absolutely matters politically’: Swing-district Republicans alarmed at spiking health insurance premiums tipping midterms
By Marc Levy, Kevin Freking and The Associated PressDecember 8, 2025
4 days ago

Most Popular

placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
2 days ago
placeholder alt text
Investing
Baby boomers have now 'gobbled up' nearly one-third of America's wealth share, and they're leaving Gen Z and millennials behind
By Sasha RogelbergDecember 8, 2025
4 days ago
placeholder alt text
Success
Palantir cofounder calls elite college undergrads a ‘loser generation’ as data reveals rise in students seeking support for disabilities, like ADHD
By Preston ForeDecember 11, 2025
20 hours ago
placeholder alt text
Economy
‘We have not seen this rosy picture’: ADP’s chief economist warns the real economy is pretty different from Wall Street’s bullish outlook
By Eleanor PringleDecember 11, 2025
1 day ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
16 days ago
placeholder alt text
Economy
‘Be careful what you wish for’: Top economist warns any additional interest rate cuts after today would signal the economy is slipping into danger
By Eva RoytburgDecember 10, 2025
2 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.